Emergent BioSolutions Inc - Company Profile

Powered by

All the sales intelligence you need on Emergent BioSolutions Inc in one solution.

  • Save hours of research time with a comprehensive
    Sales Intelligence Solution.

  • Understand how Emergent BioSolutions Inc fits into your total
    addressable market and Ideal Customer Profile.

  • Gain competitive edge with triggers that tell you
    when and how to engage with Emergent BioSolutions Inc.

Back to companies

Emergent BioSolutions Inc: Executives

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

The following section provides information on Emergent BioSolutions Inc’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Emergent BioSolutions Inc's management and employees, unlock the full data with our company analytics monitoring tool.

Executives

Zsolt Harsanyi

Chairman Executive Board Since: 2022 Age: 82

Dr. Zsolt Harsanyi has been the Chairman of the company since 2022. Prior to this, he served as the Chairman of N-Gene Research Laboratories Inc. Previously, he served as the Chief Executive Officer and Chairman of Exponential Biotherapies Inc from 2004 to 2011. Dr. Harsanyi also served as the Director of Aptevo Therapeutics Inc and President at Porton International Plc.

Read Hide full bio of Zsolt Harsanyi

Joseph C. Papa

Director; President; Chief Executive Officer Executive Board Since: 2024 Age: 70

Mr. Joseph C. Papa has been the Chief Executive Officer, Director, and President of the company since 2024. Prior to this, he served as the Chief Executive Officer and Chairman at Bausch and Lomb Corporation. Previously, he served as the Chief Executive Officer and Chairman of Bausch Health. Mr. Papa also served as the Chairman and Chief Executive Officer of Perrigo. Currently, he serves as the Chairman of the Board of SparingVision.

Read Hide full bio of Joseph C. Papa

Richard S. Lindahl

Chief Financial Officer; Executive Vice President Senior Management Since: 2018 Age: 62

Mr. Richard S. Lindahl has been the Chief Financial Officer and Executive Vice President of the company since 2018. Prior to this, he served as Treasurer of the company from 2018 to 2025. Previously, he served as the Chief Financial Officer of CEB Inc from 2009 to 2017. He served as the Senior Vice President, Vice President and Treasurer of Sprint Nextel Corporation from 2006 to 2008.

Read Hide full bio of Richard S. Lindahl

Simon Lowry

Head - Research and Development; Chief Medical Officer Senior Management Since: 2024 Age: 53

Mr. Simon Lowry has been the Chief Medical Officer and Head of Research and Development of the company since 2024. Prior to this, he served as the Chief Executive Officer of Mysthera Therapeutics AG from 2023 to 2024. He served as Chief Medical Officer of Zenas BioPharma from 2022 to 2023. He served as Chief Medical Officer of Kinevant Sciences from 2020 to 2022. Mr. Lowry served as Head of Immunology Research & Development of Roivant Sciences from 2019 to 2021.

Read Hide full bio of Simon Lowry

Stephanie Duatschek

Chief Global Strategy and Franchise Development Officer Senior Management

Ms. Stephanie Duatschek is the Chief Global Strategy and Franchise Development Officer of the company.

Read Hide full bio of Stephanie Duatschek
Gain a 360-degree view of Emergent BioSolutions Inc and make more informed decisions for your business Gain a 360-degree view of Emergent BioSolutions Inc and make more informed decisions for your business Learn more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer